Mongolian medicine for treating coronary heart disease and preparation method thereof

A technology for coronary heart disease and medicinal residues, applied in the field of Mongolian traditional Chinese medicine, can solve the problems of high price, consumers cannot afford the price, and high manufacturing cost of dripping pills

Inactive Publication Date: 2020-10-27
INNER MONGOLIA TIANQI HAN&MONGOLIA PHARMA CO
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

CN200910011685.9 provides a medicine dripping pill for the treatment of coronary heart disease, which is made of medicinal materials such as salvia miltiorrhiza, Piper longum, agarwood, and dalbergia through extraction, concentration, drying, pulverization, mixing, etc., and is suitable for a wide range of people, but In view of the high price of the above-mentioned medicinal materials, the manufacturing cost of dripping pills is relatively high, and many consumers cannot afford the corresponding price

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mongolian medicine for treating coronary heart disease and preparation method thereof
  • Mongolian medicine for treating coronary heart disease and preparation method thereof
  • Mongolian medicine for treating coronary heart disease and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0056] Preparation Process

[0057] Prescription: Salvia 450g, Agarwood 225g, Nutmeg 140g, Jujube 140g, Seabuckthorn 140g, Piper longum 135g, Dalbergia 98g, Rosewood 48g, Kaevil 73g. Excipients are: β-cyclodextrin, microcrystalline cellulose, magnesium stearate, micronized silica gel. This production prescription is enlarged 10 times on the basis of the original prescription.

[0058] The specific production process is as follows:

[0059] Add 8 times the amount of water for the above ten flavors, sandalwood, balsamic, red sandalwood, and nutmeg, soak for 2 hours, and reflux for 8 hours to obtain volatile oil, dregs and water extract for later use; add 4g of β-cyclopaste per ml of volatile oil The refined saturated aqueous solution was clathrated at 60°C for 2 hours to obtain the clathrate of volatile oil for future use. Danshen 10 times the amount of 90% ethanol is heated and refluxed for three times, each time for 1.5 hours, the extract is filtered, the filtrate is recove...

Embodiment 2

[0061] drug efficacy test

[0062] (1) Case selection: 60 cases in this group are all patients with chronic stable angina pectoris (level II, III) who belong to Qi deficiency and blood stasis syndrome according to TCM syndrome differentiation, aged 40-60 years old, with an average age of 50 years old, including 38 males and 22 females. example. Randomly select 30 cases of the observation group of the pharmaceutical preparation of the present invention, and 30 cases of the control group of the traditional Chinese medicine Liyan Jiedu Granules.

[0063] (2) Observation method: Dosing method: 3 capsules / time, three times a day, after meals, for one month; regularly observe the patient's condition changes every week, to check the patient's angina pectoris attack, ECG changes, and clinical symptoms before and after treatment (chest tightness, chest pain, palpitations, shortness of breath, fatigue, etc.); according to the clinical observation table, observe and record the patient's...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a Mongolian medicine for treating the coronary heart disease and a preparation method thereof. The Mongolian medicine comprises the following components by weight: 450 g of radix salviae miltiorrhizae, 225 g of lignum aquilariae resinatum, 140 g of nutmeg, 140 g of fructus choerospondiatis, 140 g of fructus hippopha, 135 g of fructus piperis longi, 98 g of lignum dalbergiaeodoriferae, 48 g of lignum pterocarri and 73 g of rhizoma kaempferiae. Tests show that the Mongolian medicine can obviously change clinical symptoms of patients with the coronary heart disease and the angina pectoris, and the effective rate of the clinical symptoms reaches 95%.

Description

technical field [0001] The invention belongs to the technical field of Mongolian traditional Chinese medicine, and in particular relates to a Mongolian medicine for treating coronary heart disease and a preparation method thereof. Background technique [0002] Coronary heart disease angina pectoris belongs to the category of Mongolian medicine "Jiru very Heyhat Gaga disease", which is characterized by sudden precordial angina, unfixed symptoms of angina, and can radiate to the left upper arm to the left ring finger, etc. One of heart diseases, shortness of breath, chest tightness, fatigue and other symptoms may appear during the onset. The disease was first recorded in the "Sibu Medical Classics", and it is divided into two types: Heyi type heart tingling and Qisu type heart tingling, and is described in terms of symptoms and treatment. Mongolian medicine believes that the disease is caused by the imbalance of the three roots (Heyi, Xiri, and Badakan) in the body, poor bloo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/906A61K47/69A61P9/10
CPCA61K36/185A61K36/22A61K36/48A61K36/537A61K36/67A61K36/835A61K36/906A61K2236/331A61K2236/333A61K47/6951A61P9/10A61K2300/00
Inventor 韩风雨于秀玲艾林孟令江上官同强
Owner INNER MONGOLIA TIANQI HAN&MONGOLIA PHARMA CO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap